Alex Colville
Venture investor focused on longevity biotech, co-founder/partner at age1 with experience deploying family office capital into longevity startups and writing about market potential for aging therapeutics.
Top 3 podcasts with Alex Colville
Ranked by the Snipd community
Jul 5, 2024 • 48min
How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
In this discussion, venture investor Alex Colville, co-founder of age1, shares his journey from an early interest in longevity to deploying over $100 million into biotech startups. He emphasizes the significance of founder-market fit and the unexpected scalability of small investments. The conversation turns to the potential of the first longevity-approved drug, which could generate up to $200 billion annually. Alex also explores the exciting world of synthetic embryos and the bold risks necessary for early-stage investments.
Oct 13, 2023 • 43min
Age1’s Alex Colville: “Inventing the anti-ageing pill”
Alex Colville, co-founder of Age1, talks about funding longevity science, studying the biology of ageing, the rise of geroscience, healthspan, the potential of metformin, working on an anti-ageing treatment, and how long he thinks we'll live.
Apr 10, 2024 • 38min
The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville
Two experts in the longevity industry, Joe Betts-LaCroix and Alex Colville, discuss the past, present, and future of longevity including evaluating founders, societal impacts, and the business case for longevity drugs. They explore challenges in FDA approval, risks in the biotech industry, and misconceptions surrounding longevity.
